Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-13

FDA Approved: LABETALOL HYDROCHLORIDE — Original Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approved labetalol hydrochloride as a generic drug under an original application from Cadila Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Labetalol Hydrochloride (Labetalol hydrochloride)

Snippet

ORIG AP for LABETALOL HYDROCHLORIDE (LABETALOL HYDROCHLORIDE)